ad

Nifty Pharma Prediction for Tomorrow: A Sharp Reversal Heads Into Monday, 20 July 2026

Nifty Pharma prediction for tomorrow: index closed Friday at 25,645.00, down 1.40 percent, the sole major sectoral decliner. Support 25,550. Resistance 25,980.


17 Jul 20264:22 pm

Nifty Pharma Prediction for Tomorrow: A Sharp Reversal Heads Into Monday, 20 July 2026

Nifty pharma prediction for tomorrow: Pharma stocks close the trading week on a distinctly weaker note, with Nifty Pharma finishing Friday at 25,645.00, down 1.40 percent, the sole major sectoral decliner even as the broader market posted its strongest session in weeks. This nifty pharma prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Ankit Jaiswal, Senior Research Analyst at Univest, frames this Nifty Pharma prediction for tomorrow around a decisive rotation story worth understanding before Monday, since Friday’s sharp decline came precisely on the day money moved into cyclical, largecap-led names like IT and banking instead.

Click Here – Get Free Investment Predictions

Market Recap Behind the Nifty pharma prediction for tomorrow

Friday’s session opened at 25,978.70, fell to a low of 25,549.25 and closed at 25,645.00, the index’s weakest finish in over a week, decisively reversing the sector’s earlier gains from Tuesday and Wednesday. With nothing trading over the weekend, this Nifty Pharma prediction for tomorrow carries that reversal forward into Monday’s session.

Nifty pharma prediction for tomorrow: Trend and Key Levels

Trend: Bearish Below 25,980 Heading Into the Reopen

Level Type Value
Support 1 25,550
Support 2 25,400
Resistance 1 25,980
Resistance 2 26,150

Ankit Jaiswal’s Nifty Pharma prediction for tomorrow keeps 25,550 as the floor worth watching Monday, with 25,980 the resistance that would need reclaiming to suggest the sector is regaining favour for the new week.

A Rotation Away From Defensives, Not a Change in Fundamentals

Markets have been shut since Friday’s close, so this is written for Sunday readers checking sector levels ahead of Monday’s reopening. Friday itself brought a genuinely broad Indian equity rally on IT and banking strength, even as crude oil kept climbing for a fifth straight session on the unresolved Strait of Hormuz standoff. Watch GIFT Nifty and Asian cues Monday morning for the first live read on how the weekend has been digested. Pharma remains largely insulated from these particular cues, and Friday’s sharp decline reads far more like a clear rotation shift into cyclicals than any change in the sector’s own underlying defensive fundamentals.

Key Triggers in the Nifty pharma prediction for tomorrow

These triggers dominate the outlook heading into Monday, 13 July 2026:

  • Whether cyclicals keep leading: If IT and banking continue dominating flows Monday, pharma could see further underperformance.
  • US generic pricing news: Any regulatory or pricing developments remain an added sector-specific catalyst worth watching.
  • HCL Technologies closed the week up 2.42 percent at Rs 1,203.90, its third straight positive session, having now fully recovered from Tuesday’s post-results crash.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Stocks to Watch in the Pharma Sector

Key constituents worth checking before Monday’s open.

Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals.

Nifty IT: Nifty IT jumped 1.75 percent Friday, a primary destination for the money rotating out of pharma.

Risks to the Nifty pharma prediction for tomorrow

These factors can invalidate this outlook:

  • Continued rotation into cyclicals: If IT and banking keep leading, pharma could see further relative underperformance.
  • A US regulatory setback: Any adverse FDA decision would compound the sector’s current weakness.
  • A weekend risk-off reversal: Ironically, a market-wide sell-off could actually benefit pharma as investors rotate back into defensives.

Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.

Conclusion

This Nifty Pharma prediction for tomorrow stays bearish below 25,980, reflecting a sector that decisively reversed its earlier weekly gains as money rotated sharply into cyclicals on Friday. Ankit Jaiswal’s 25,550 support is the number to know Monday morning, with a reversal of the current rotation pattern the clearest path back to renewed sector strength.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty pharma prediction for tomorrow

Checking this over the weekend, what’s the Nifty Pharma prediction for tomorrow?

Ans. Based on Friday’s close, the Nifty Pharma prediction for tomorrow, Monday 20 July 2026, is bearish below 25,980. The index closed at 25,645.00, down 1.40 percent, the sole major sectoral decliner.

Who prepared this Nifty Pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest, prepared this Nifty Pharma prediction for tomorrow, flagging 25,550 as the key support level.

Why did pharma fall while other sectors rallied on Friday?

Ans. This is the central point of the Nifty Pharma prediction for tomorrow: pharma fell precisely as the broader market posted its strongest session in weeks, led by IT and banking instead, confirming a clear and decisive rotation away from defensives.

Did pharma’s earlier gains this week get fully wiped out?

Ans. Friday’s 1.40 percent decline more than offset the sector’s earlier Tuesday and Wednesday gains, which the Nifty Pharma prediction for tomorrow reads as confirmation this was a genuine reversal rather than a brief pause.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down